ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A04AA02 | G | Granisetron - 3mg/3ml | 8437 | 120215/1 | GRANI-DENK | 3mg/3ml | 5 x 3ml | Injectable concentrate for solution | Infusion/IV | Mediterranean Pharmaceutical Company | Solupharm Pharmazeutische Erzeugnisse GmbH | Germany | 1,679,803 L.L | 23.08 | B | Denk Pharma GmbH & Co, KG | Germany | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A04AA02 | B | Granisetron (HCl) - 3mg/3ml | 9852 | 188818/1 | KYTRIL | 3mg/3ml | 5 x 3ml | Injectable solution | Infusion/IV/IM | Omnipharma | Cenexi SAS | France | 3,711,021 L.L | 23.08 | B | Atnahs Pharma UK Limited | UK | 2/5/2024 | 0 |